| Literature DB >> 28697342 |
Qianghu Wang1, Baoli Hu2, Xin Hu3, Hoon Kim4, Massimo Squatrito5, Lisa Scarpace6, Ana C deCarvalho6, Sali Lyu7, Pengping Li7, Yan Li7, Floris Barthel4, Hee Jin Cho8, Yu-Hsi Lin9, Nikunj Satani9, Emmanuel Martinez-Ledesma10, Siyuan Zheng10, Edward Chang10, Charles-Etienne Gabriel Sauvé2, Adriana Olar11, Zheng D Lan2, Gaetano Finocchiaro12, Joanna J Phillips13, Mitchel S Berger13, Konrad R Gabrusiewicz14, Guocan Wang2, Eskil Eskilsson10, Jian Hu2, Tom Mikkelsen15, Ronald A DePinho2, Florian Muller16, Amy B Heimberger14, Erik P Sulman17, Do-Hyun Nam18, Roel G W Verhaak19.
Abstract
We leveraged IDH wild-type glioblastomas, derivative neurospheres, and single-cell gene expression profiles to define three tumor-intrinsic transcriptional subtypes designated as proneural, mesenchymal, and classical. Transcriptomic subtype multiplicity correlated with increased intratumoral heterogeneity and presence of tumor microenvironment. In silico cell sorting identified macrophages/microglia, CD4+ T lymphocytes, and neutrophils in the glioma microenvironment. NF1 deficiency resulted in increased tumor-associated macrophages/microglia infiltration. Longitudinal transcriptome analysis showed that expression subtype is retained in 55% of cases. Gene signature-based tumor microenvironment inference revealed a decrease in invading monocytes and a subtype-dependent increase in macrophages/microglia cells upon disease recurrence. Hypermutation at diagnosis or at recurrence associated with CD8+ T cell enrichment. Frequency of M2 macrophages detection associated with short-term relapse after radiation therapy.Entities:
Keywords: disease recurrence; glioblastoma; immune cells; macrophages/microglia; mesenchymal subtype; proneural to mesenchymal transition; tumor evolution; tumor microenvironment
Mesh:
Year: 2017 PMID: 28697342 PMCID: PMC5599156 DOI: 10.1016/j.ccell.2017.06.003
Source DB: PubMed Journal: Cancer Cell ISSN: 1535-6108 Impact factor: 31.743